Cardiac magnetic resonance angiography using blood-pool contrast agents: Comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 184, Issue 2, 2012, Pages 105-112

  Schnorr, J ^a   Taupitz, M ^a   Schellenberger, E A ^a   Warmuth, C ^a   Fahlenkamp, U L ^a,b   Wagner, S ^a   Kaufels, N ^a   Wagner, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

blood vessels; contrast agents; experimental study; heart

Indexed keywords

CITRIC ACID; GADOFOSVESET; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; VERY SMALL SUPERPARAMAGNETIC IRON OXIDE PARTICLE;

ANIMAL EXPERIMENT; ARTICLE; CARDIAC GATED IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST TO NOISE RATIO; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; ELECTRICAL PARAMETERS; ELECTROCARDIOGRAM; ELECTROCARDIOGRAM GATED INVERSION RECOVERY PREPARED STEADY STATE FREE PRECESSION IMAGING; ELECTROCARDIOGRAM GATED INVERSION RECOVERY PREPARED T1 WEIGHTED GRADIENT ECHO IMAGING; EXPERIMENTAL PIG; HEART MUSCLE; MAGNETIC RESONANCE ANGIOGRAPHY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FERUMOXYTOL; GADOLINIUM; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE ANGIOGRAPHY; ORGANOMETALLIC COMPOUNDS; SENSITIVITY AND SPECIFICITY; SWINE;

EID: 84856297624     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0031-1281982     Document Type: Article

References (29)

1. Lauffer RB, Parmelee DJ, Dunham SU et al. MS-325: albumin-targeted contrast agent for MR angiography. Radiology: 1998; 207 529 538 (Pubitemid 28259074)
2. Port M, Corot C, Violas X et al. How to compare the efficiency of albumin-bound and nonalbumin-bound contrast agents in vivo: the concept of dynamic relaxivity. Invest Radiol: 2005; 40 565 573 (Pubitemid 41208633)
3. Bluemke DA, Stillman AE, Bis KG et al. Carotid MR angiography: phase II study of safety and efficacy for MS-325. Radiology: 2001; 219 114 122 (Pubitemid 32234062)
4. Corot C, Violas X, Robert P et al. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol: 2003; 38 311 319 (Pubitemid 36627248)
5. Goyen M, Shamsi K, Schoenberg SO. Vasovist-enhanced MR angiography. Eur Radiol: 2006; 16 B9 B14
6. Prompona M, Cyran C, Nikolaou K et al. Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gadofosveset. Invest Radiol: 2009; 44 369 374
7. Wagner M, Rief M, Asbach P et al. Gadofosveset trisodium-enhanced magnetic resonance angiography of the left atrium a feasibility study. Eur J Radiol: 2010; 75 166 172
8. Wagner M, Rosler R, Lembcke A et al. Whole-heart coronary magnetic resonance angiography at 1.5 Tesla: does a blood-pool contrast agent improve diagnostic accuracy? Invest Radiol: 2011; 46 152 159
9. Taupitz M, Schnorr J, Abramjuk C et al. New generation of monomer-stabilized very small superparamagnetic iron oxide particles (VSOP) as contrast medium for MR angiography: preclinical results in rats and rabbits. J Magn Reson Imaging: 2000; 12 905 911
10. Wagner S, Schnorr J, Pilgrimm H et al. Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization. Invest Radiol: 2002; 37 167 177 (Pubitemid 34259726)
11. Allkemper T, Bremer C, Matuszewski L et al. Contrast-enhanced blood-pool MR angiography with optimized iron oxides: effect of size and dose on vascular contrast enhancement in rabbits. Radiology: 2002; 223 432 438 (Pubitemid 34454322)
12. Taupitz M, Schnorr J, Wagner S et al. Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium. Radiology: 2002; 222 120 126 (Pubitemid 34031476)
13. Taupitz M, Wagner S, Schnorr J et al. Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging. Invest Radiol: 2004; 39 394 405 (Pubitemid 38802814)
14. Wagner M, Wagner S, Schnorr J et al. Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: Initial experience in humans. J Magn Reson Imaging: 2011; 10.1002/jmri.22683
15. Rohrer M, Bauer H, Mintorovitch J et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol: 2005; 40 715 724 (Pubitemid 41546838)
16. Schnorr J, Wagner S, Ebert W et al. MR-Angiographie der Koronararterien: Vergleich des Blutpoolkontrastmittels Gadomer mit Gd-DTPA am Schwein. Fortschr Rntgenstr: 2003; 175 822 829 (Pubitemid 36806766)
17. Li D, Zheng J, Weinmann HJ. Contrast-enhanced MR imaging of coronary arteries: comparison of intra- and extravascular contrast agents in swine. Radiology: 2001; 218 670 678 (Pubitemid 32172546)
18. Fink C, Goyen M, Lotz J. Magnetic resonance angiography with blood-pool contrast agents: future applications. Eur Radiol: 2007; 17 B38 B44
19. Stuber M, Botnar RM, Danias PG et al. Contrast agent-enhanced, free-breathing, three-dimensional coronary magnetic resonance angiography. J Magn Reson Imaging: 1999; 10 790 799 (Pubitemid 29519783)
20. Huber ME, Paetsch I, Schnackenburg B et al. Performance of a new gadolinium-based intravascular contrast agent in free-breathing inversion-recovery 3D coronary MRA. Magn Reson Med: 2003; 49 115 121 (Pubitemid 36042340)
21. de Haen C, Anelli PL, Lorusso V et al. Gadocoletic acid trisodium salt (b22956/1): a new blood pool magnetic resonance contrast agent with application in coronary angiography. Invest Radiol: 2006; 41 279 291 (Pubitemid 44406189)
22. Herborn CU, Barkhausen J, Paetsch I et al. Coronary arteries: contrast-enhanced MR imaging with SH L 643A experience in 12 volunteers. Radiology: 2003; 229 217 223 (Pubitemid 37152127)
23. Dirksen MS, Lamb HJ, Kunz P et al. Improved MR coronary angiography with use of a new rapid clearance blood pool contrast agent in pigs. Radiology: 2003; 227 802 808 (Pubitemid 36583040)
24. Taupitz M, Schmitz S, Hamm B. Superparamagnetische Eisenoxidpartikel: Aktueller Stand und zuknftige Entwicklungen. Fortschr Rntgenstr: 2003; 175 752 765 (Pubitemid 36806756)
25. Weissleder R, Elizondo G, Wittenberg J et al. Ultrasmall superparamagnetic iron oxide: characterization of a new class of contrast agents for MR imaging. Radiology: 1990; 175 489 493 (Pubitemid 20135290)
26. Warmuth C, Schnorr J, Kaufels N et al. Whole-heart coronary magnetic resonance angiography: contrast-enhanced high-resolution, time-resolved 3D imaging. Invest Radiol: 2007; 42 550 557 (Pubitemid 47051831)
27. Stark DD, Weissleder R, Elizondo G et al. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver. Radiology: 1988; 168 297 301
28. Kaufels N, Korn R, Wagner S et al. Magnetic resonance imaging of liver metastases: experimental comparison of anionic and conventional superparamagnetic iron oxide particles with a hepatobiliary contrast medium during dynamic and uptake phases. Invest Radiol: 2008; 43 496 503
29. Schnorr J, Wagner S, Abramjuk C et al. Focal liver lesions: SPIO-, gadolinium- and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits. Radiology: 2006; 240 90 100 (Pubitemid 43902598)